about
The role of HDAC6 in cancerHistone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in miceHistone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4.Valproic acid induces monoamine oxidase A via Akt/forkhead box O1 activationSubstrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complexValproic acid teratogenicity: a toxicogenomics approachPost-Translational Modifications of Histones in Vertebrate NeurogenesisEpigenetics and psychostimulant addictionDesign of small molecule epigenetic modulatorsThe TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and diseaseEpigenetics of Renal Development and DiseaseAdvancements in the delivery of epigenetic drugsHDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeuticsBalancing cell numbers during organogenesis: Six1a differentially affects neurons and sensory hair cells in the inner ear.Multi-tasking on chromatin with the SAGA coactivator complexes.Histone deacetylase activity is necessary for left-right patterning during vertebrate developmentSIRT1 shows no substrate specificity in vitro.Diversity-oriented synthesis: exploring the intersections between chemistry and biology.Comparative genomics of the class 4 histone deacetylase family indicates a complex evolutionary historyGenetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivoPharmacology of epigenetics in brain disordersSeparating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Class II histone deacetylases: from sequence to function, regulation, and clinical implication.Epigenetic changes in the myelodysplastic syndrome.Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myelomaHistone acetylation affects expression of cellular patterning genes in the Arabidopsis root epidermisSorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells.Inhibition of class IIb histone deacetylase significantly improves cloning efficiency in mice.New insights into the treatment of multiple myeloma with histone deacetylase inhibitors.Potential role for PADI-mediated histone citrullination in preimplantation developmentDNA and histone deacetylases as targets for neuroblastoma treatment.FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage responseActivation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3.Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice.New insights into BS69 functions.Cell cycle molecules define a pathway required for neuron death in development and disease.Radioprotective effects of valproic acid, a histone deacetylase inhibitor, in the rat brainHistone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson diseaseAcetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor.
P2860
Q21296746-D66EC75F-E0DF-44EC-84FB-257699EC95CFQ24288997-539CC5A8-9A8A-4B80-9D45-C22DC49BDBF1Q24299472-D011C0D6-E441-44C8-BD05-F494B0C9D72AQ24635235-307169AD-77AC-4BCF-9ACB-8F8AE671A07FQ24684832-E253B2F3-CA1F-4558-BFC4-F454EE378C4FQ24813390-59994197-B22B-48DF-8094-DA7E442515C2Q26770764-8755E674-B1BD-448F-91A4-9BF4A96817FCQ26829156-3716CBCB-F8FA-4F8E-A274-6128F69554A5Q26850027-EDB9A10C-6D93-4789-9408-87BCFCAE43B5Q26999255-57AA47DD-7C1F-4665-B852-45224C138941Q28079434-C613ABAC-26CA-47AF-AEA4-51D218F6BB7CQ28088478-AE653F32-555F-4A4D-840E-5662EAAD88F6Q28290352-536B2296-4B68-491D-808D-E636F9E72E15Q30425138-AF96488C-F6FA-4CF2-A29D-633D6682EED3Q30443104-3863C098-073B-42EB-A29D-B6E323961A49Q31013236-E7C0A3FE-6093-42FD-87DA-D045E67D1A99Q33210693-403AEE03-A250-48CD-A882-A29B7B98B7ACQ33231454-A43781A9-3B48-4BF5-A3DD-2C0F0AC85F41Q33252627-B95BED19-3D3E-43D2-A864-E7F6DA309239Q33270804-062C993D-3D2E-4D53-9AE6-663313655CE2Q33270812-9DD57BD5-2384-4C8C-A42C-4F64FE41AC7CQ33673025-9B217988-8A9F-45FF-9F86-5D4F715586A3Q33685495-7863FCFA-07EA-4190-A505-5A02A10913E2Q33724483-4E53A98B-C1FF-49A8-B170-D5156B268798Q33767309-E8943ECD-0BAB-45DA-BECF-3843481DF0BBQ33854012-B882D3DC-B927-4D7A-98F5-6833D09F51F3Q34063461-FAA55E1E-DA85-4FA3-B879-18EE00D794FEQ34104350-147E4DD1-A9FA-4589-B43F-121EA5CC38C8Q34129766-1C51C54C-9986-449C-9122-8CFC6557C7B2Q34224278-C49ECEF7-4182-4D9E-A2D0-4E17BDDF74CEQ34308802-0529A9F0-FD0C-4DB9-A2F0-F26526C8D9ADQ34320121-C0D79BB0-1FB8-4042-A3AC-618DA8E42EA7Q34335528-5E825A75-E613-41EB-AA4C-05AD99E5A81AQ34347410-408813B0-D493-448F-AB89-C6A203A08978Q34355738-88EA323C-7642-4E80-AE37-1623731B9405Q34505578-1958CBC3-5894-4CE7-8382-856A179E677AQ34602967-C58C22A6-C061-49C5-BC4E-3E902D97790CQ34607271-8856BAA5-D1F7-4CF3-9159-47AE8ECB28B8Q34683308-168D918C-4B95-4EF4-B656-8AE22C64BC00Q34698474-A392EB31-BAE3-4DF4-A43F-0ACABE172071
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Histone deacetylases.
@ast
Histone deacetylases.
@en
type
label
Histone deacetylases.
@ast
Histone deacetylases.
@en
prefLabel
Histone deacetylases.
@ast
Histone deacetylases.
@en
P2093
P1476
Histone deacetylases.
@en
P2093
Paul A Marks
Thomas Miller
Victoria M Richon
P304
P356
10.1016/S1471-4892(03)00084-5
P577
2003-08-01T00:00:00Z